Titre : N-oxydes cycliques

N-oxydes cycliques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Accuracy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "N-oxydes cycliques : Questions médicales les plus fréquentes", "headline": "N-oxydes cycliques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les N-oxydes cycliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "N-oxydes cycliques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oxydes hétérocycliques", "url": "https://questionsmedicales.fr/mesh/D006577", "about": { "@type": "MedicalCondition", "name": "Oxydes hétérocycliques", "code": { "@type": "MedicalCode", "code": "D006577", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.661" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "4-Hydroxyamino quinoléine 1-oxyde", "alternateName": "4-Hydroxyaminoquinoline-1-oxide", "url": "https://questionsmedicales.fr/mesh/D015108", "about": { "@type": "MedicalCondition", "name": "4-Hydroxyamino quinoléine 1-oxyde", "code": { "@type": "MedicalCode", "code": "D015108", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.661.243.320" } } }, { "@type": "MedicalWebPage", "name": "4-Nitro-quinoléine-1-oxyde", "alternateName": "4-Nitroquinoline-1-oxide", "url": "https://questionsmedicales.fr/mesh/D015112", "about": { "@type": "MedicalCondition", "name": "4-Nitro-quinoléine-1-oxyde", "code": { "@type": "MedicalCode", "code": "D015112", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.661.243.500" } } }, { "@type": "MedicalWebPage", "name": "2,2,6,6-Tétraméthyl-4-oxo-pipéridin-1-oxyle", "alternateName": "Triacetoneamine-N-Oxyl", "url": "https://questionsmedicales.fr/mesh/D014216", "about": { "@type": "MedicalCondition", "name": "2,2,6,6-Tétraméthyl-4-oxo-pipéridin-1-oxyle", "code": { "@type": "MedicalCode", "code": "D014216", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.661.243.930" } } } ], "about": { "@type": "MedicalCondition", "name": "N-oxydes cycliques", "alternateName": "Cyclic N-Oxides", "code": { "@type": "MedicalCode", "code": "D003497", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Youai Qiu", "url": "https://questionsmedicales.fr/author/Youai%20Qiu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory and Institute of Elemento-Organic Chemistry, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, 94 Weijin Road, Tianjin, 300071, China." } }, { "@type": "Person", "name": "Jiawei Wang", "url": "https://questionsmedicales.fr/author/Jiawei%20Wang", "affiliation": { "@type": "Organization", "name": "Xi'an University of Technology, China; State Key Laboratory of Eco-hydraulics in Northwest Arid Region of China, Xi'an University of Technology, Xi'an, 710048, China." } }, { "@type": "Person", "name": "Wei Wu", "url": "https://questionsmedicales.fr/author/Wei%20Wu", "affiliation": { "@type": "Organization", "name": "Xi'an University of Technology, China; State Key Laboratory of Eco-hydraulics in Northwest Arid Region of China, Xi'an University of Technology, Xi'an, 710048, China. Electronic address: wuwei@xaut.edu.cn." } }, { "@type": "Person", "name": "Yaqi Huang", "url": "https://questionsmedicales.fr/author/Yaqi%20Huang", "affiliation": { "@type": "Organization", "name": "Xi'an University of Technology, China; State Key Laboratory of Eco-hydraulics in Northwest Arid Region of China, Xi'an University of Technology, Xi'an, 710048, China." } }, { "@type": "Person", "name": "Maosheng Zheng", "url": "https://questionsmedicales.fr/author/Maosheng%20Zheng", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Regional Energy Systems Optimization, Ministry of Education, College of Environmental Science and Technology, North China Electric Power University, Beijing, 102206, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Excellent agreement of Norwegian trauma registry data compared to corresponding data in electronic patient records.", "datePublished": "2023-09-26", "url": "https://questionsmedicales.fr/article/37752614", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13049-023-01118-5" } }, { "@type": "ScholarlyArticle", "name": "Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality.", "datePublished": "2023-09-27", "url": "https://questionsmedicales.fr/article/37759205", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-023-09965-9" } }, { "@type": "ScholarlyArticle", "name": "Mdwgan-gp: data augmentation for gene expression data based on multiple discriminator WGAN-GP.", "datePublished": "2023-11-13", "url": "https://questionsmedicales.fr/article/37957576", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12859-023-05558-9" } }, { "@type": "ScholarlyArticle", "name": "Thirty-three myths and misconceptions about population data: from data capture and processing to linkage.", "datePublished": "2023-01-31", "url": "https://questionsmedicales.fr/article/37636835", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.23889/ijpds.v8i1.2115" } }, { "@type": "ScholarlyArticle", "name": "Accuracy of ethnicity records at primary and secondary healthcare services in Waikato region, Aotearoa New Zealand.", "datePublished": "2024-09-06", "url": "https://questionsmedicales.fr/article/39236329", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.26635/6965.6445" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Oxydes hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006577" }, { "@type": "ListItem", "position": 4, "name": "N-oxydes cycliques", "item": "https://questionsmedicales.fr/mesh/D003497" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : N-oxydes cycliques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur N-oxydes cycliques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur N-oxydes cycliques", "description": "Comment diagnostiquer une intoxication aux N-oxydes cycliques ?\nQuels tests sont utilisés pour détecter les N-oxydes cycliques ?\nQuels symptômes indiquent une exposition aux N-oxydes cycliques ?\nLes N-oxydes cycliques sont-ils visibles sur des imageries médicales ?\nPeut-on identifier les N-oxydes cycliques dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Data+Accuracy&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur N-oxydes cycliques", "description": "Quels sont les symptômes d'une exposition aiguë ?\nLes N-oxydes cycliques provoquent-ils des allergies ?\nY a-t-il des symptômes chroniques liés aux N-oxydes cycliques ?\nLes symptômes varient-ils selon le type de N-oxyde ?\nComment les symptômes évoluent-ils avec le temps ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Data+Accuracy&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur N-oxydes cycliques", "description": "Comment prévenir l'exposition aux N-oxydes cycliques ?\nDes formations sont-elles nécessaires pour manipuler ces composés ?\nQuels équipements de protection sont recommandés ?\nLes réglementations aident-elles à prévenir l'exposition ?\nComment évaluer les risques d'exposition ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Data+Accuracy&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur N-oxydes cycliques", "description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes existent-ils pour les N-oxydes cycliques ?\nComment traiter les symptômes respiratoires ?\nLe traitement nécessite-t-il une hospitalisation ?\nY a-t-il des traitements préventifs disponibles ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Data+Accuracy&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur N-oxydes cycliques", "description": "Quelles complications peuvent survenir après exposition ?\nLes N-oxydes cycliques peuvent-ils causer des cancers ?\nY a-t-il des effets à long terme sur la santé ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Data+Accuracy&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur N-oxydes cycliques", "description": "Quels sont les principaux facteurs de risque d'exposition ?\nL'âge influence-t-il la sensibilité aux N-oxydes cycliques ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes femmes enceintes sont-elles plus à risque ?\nLe mode de vie influence-t-il le risque d'exposition ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Data+Accuracy&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux N-oxydes cycliques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les N-oxydes cycliques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses chromatographiques et spectrométriques sont couramment utilisées." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux N-oxydes cycliques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles respiratoires, des nausées et des vertiges." } }, { "@type": "Question", "name": "Les N-oxydes cycliques sont-ils visibles sur des imageries médicales ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils ne sont pas visibles sur les imageries médicales standard." } }, { "@type": "Question", "name": "Peut-on identifier les N-oxydes cycliques dans le sang ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins spécifiques peuvent détecter leur présence." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition aiguë ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes aigus incluent des maux de tête, des nausées et des troubles neurologiques." } }, { "@type": "Question", "name": "Les N-oxydes cycliques provoquent-ils des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des réactions allergiques chez certaines personnes sensibles." } }, { "@type": "Question", "name": "Y a-t-il des symptômes chroniques liés aux N-oxydes cycliques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut entraîner des problèmes respiratoires chroniques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de N-oxyde ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de la structure chimique spécifique." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver avec une exposition continue ou répétée." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux N-oxydes cycliques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire." } }, { "@type": "Question", "name": "Des formations sont-elles nécessaires pour manipuler ces composés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation adéquate est essentielle pour manipuler ces substances en toute sécurité." } }, { "@type": "Question", "name": "Quels équipements de protection sont recommandés ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des gants, des lunettes de protection et des masques respiratoires sont recommandés." } }, { "@type": "Question", "name": "Les réglementations aident-elles à prévenir l'exposition ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réglementations strictes encadrent l'utilisation de ces composés dans l'industrie." } }, { "@type": "Question", "name": "Comment évaluer les risques d'exposition ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des évaluations de risques régulières doivent être effectuées dans les environnements de travail." } }, { "@type": "Question", "name": "Quel est le traitement principal en cas d'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est l'élimination de l'exposition et le soutien symptomatique." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les N-oxydes cycliques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antidote spécifique pour ces composés." } }, { "@type": "Question", "name": "Comment traiter les symptômes respiratoires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les bronchodilatateurs et les corticostéroïdes peuvent être utilisés pour soulager les symptômes." } }, { "@type": "Question", "name": "Le traitement nécessite-t-il une hospitalisation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une hospitalisation peut être nécessaire en cas de symptômes graves ou persistants." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs disponibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des mesures de sécurité et des équipements de protection individuelle sont recommandés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications respiratoires et neurologiques peuvent survenir après exposition." } }, { "@type": "Question", "name": "Les N-oxydes cycliques peuvent-ils causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme sur la santé ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets à long terme incluent des troubles respiratoires chroniques et des problèmes neurologiques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications potentielles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis médicaux réguliers sont nécessaires pour surveiller les complications potentielles." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs en laboratoire et en industrie chimique sont les plus exposés." } }, { "@type": "Question", "name": "L'âge influence-t-il la sensibilité aux N-oxydes cycliques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus sensibles aux effets toxiques." } }, { "@type": "Question", "name": "Les antécédents médicaux augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies respiratoires augmentent le risque d'effets néfastes." } }, { "@type": "Question", "name": "Les femmes enceintes sont-elles plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition pendant la grossesse peut affecter le fœtus et la mère." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'exposition ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie avec des expositions professionnelles augmente le risque." } } ] } ] }

Sources (10000 au total)

Excellent agreement of Norwegian trauma registry data compared to corresponding data in electronic patient records.

The Norwegian Trauma Registry (NTR) is designed to monitor and improve the quality and outcome of trauma care delivered by Norwegian trauma hospitals. Patient care is evaluated through specific qualit... We validated 49 of the 118 variables registered in the NTR by comparing those with the corresponding ones in electronic patient records for 180 patients with a trauma diagnosis admitted in 2019 at eig... Almost perfect agreement (AC... All tested variables in the Norwegian Trauma Registry displayed excellent agreement with the corresponding variables in electronic patient records. Variables in the registry that showed missing data n...

Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality.

One crucial obstacle to attaining universal immunization coverage in Sub-Saharan Africa is the paucity of timely and high-quality data. This challenge, in part, stems from the fact that many frontline... A descriptive cross-sectional study was conducted, involving health districts and health facilities in all 10 regions in Cameroon selected by a multi-stage sampling scheme. Structured questionnaires a... A total of 265 facilities in 68 health districts were assessed. There was limited availability of some data recording tools like vaccination cards (43%), maintenance registers (8%), and stock cards (5... Our findings unveil important gaps in data collection practices at the facility level that could adversely affect Cameroon's immunization data quality. It highlights the urgent need for systematic cap...

Mdwgan-gp: data augmentation for gene expression data based on multiple discriminator WGAN-GP.

Although gene expression data play significant roles in biological and medical studies, their applications are hampered due to the difficulty and high expenses of gathering them through biological exp... In this study, an improved data augmentation approach MDWGAN-GP, a generative adversarial network model with multiple discriminators, is proposed. In addition, a novel method is devised for enriching ... The experimental results have demonstrated that compared with other state-of-the-art methods, the MDWGAN-GP method can produce higher quality generated gene expression data in most cases....

Accuracy of ethnicity records at primary and secondary healthcare services in Waikato region, Aotearoa New Zealand.

Ethnicity is an important variable, and in Aotearoa New Zealand it is used to monitor population health needs, health services outcomes and to allocate resources. However, there is a history of underc... Through individual record linkage, prospective self-reported ethnicity, collected using New Zealand Census and Ministry of Health - Manatū Hauora ethnicity protocol as a "gold standard", was compared ... Māori were undercounted in secondary NHI (32.5%) and primary care (31.3%) datasets compared to self-reported (34.6%). Between 9.5-11% of individuals had a different ethnicity recorded in health datase... Routine health datasets fail to adequately collect ethnicity, particularly for those with multiple ethnicities. Inaccuracies disproportionately affect Māori and urgent efforts are needed to improve co...

Drivers and Barriers to Improved Data Quality and Data-Use Practices: An Interpretative Qualitative Study in Addis Ababa, Ethiopia.

An objective of the Information Revolution Roadmap of Ethiopia's Health Sector Transformation Plan was to improve health management information system (HMIS) data quality and data use at the point of ... We conducted an interpretative qualitative study across all 11 health centers in 3 subcities of Addis Ababa, Ethiopia: Yeka, Akaki-Kaliti, and Ledeta. A total of 40 key informant interviews and 6 focu... Our findings indicate that the main drivers of data quality and use at the point of service delivery were the use of the Connected Woreda strategy and its tools, capacity-building activities including... Improvements in quality and use of HMIS data at health facilities are expected to result in delivering better-quality health services to the community as data enable health workers to identify gaps in...

Validation of Multi-State EHR-Based Network for Disease Surveillance (MENDS) Data and Implications for Improving Data Quality and Representativeness.

Surveillance modernization efforts emphasize the potential use of electronic health record (EHR) data to inform public health surveillance and prevention. However, EHR data streams vary widely in thei... We developed a validation process for the Multi-State EHR-Based Network for Disease Surveillance (MENDS) pilot project to identify and resolve data quality issues that could affect chronic disease pre... We identified gaps in the EHR databases of data contributors and in the processes to extract, map, integrate, and analyze their EHR data. Examples of source-data problems included missing data on race... Validation protocols identified critical errors in both EHR source data and in the processes used to transform these data for analysis. Our experience highlights the value and importance of data valid...

Optimizing data integration in trials that use EHR data: lessons learned from a multi-center randomized clinical trial.

Despite great promise, trials that ascertain patient clinical data from electronic health records (EHR), referred to here as "EHR-sourced" trials, are limited by uncertainty about how existing trial s... We describe a demonstration project that used EHR data to complement data collected for a contemporary multi-center pharmaceutical industry outcomes trial, and how a central coordinating center suppor... While broadening the type of sites able to participate in EHR-sourced trials may lead to greater generalizability and improved enrollment, sites with fewer technical resources may require additional s...